AXIOMER
LIVE

Serial Number

79192823

Owner

ProQR Therapeutics II B.V.

Attorney

Krista Weber Powell

Filing Date

Mar 23, 2016

Add to watchlist:

No watchlists yet
View on USPTO

AXIOMER Trademark

Serial Number: 79192823 • Registration: 5229979

AXIOMER is a trademark filed by ProQR Therapeutics II B.V. on March 23, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ProQR Therapeutics II B.V. (6 trademarks)

Zernikedreef 9

Entity Type: 98

Trademark Details

Filing Date

March 23, 2016

Registration Date

June 27, 2017

Published for Opposition

January 10, 2017

Cancellation Date

January 12, 2024

Goods & Services

[ Chemical compounds for scientific or research purposes ]

[ Pharmaceutical preparations for the treatment, diagnosis and prevention of genetic diseases and disorders; ] pharmaceutical preparations for the treatment of genetic diseases based on oligonucleotides, [ oligoribonucleotides, aptamers, nucleic acid molecules, dna, ] * for use in * rna [, polynucleotides, ribozymes, mirnas, snornas, mrnas or sirnas ]

[ Laboratory research services relating to pharmaceuticals; medical research; pharmaceutical research and development; laboratory research and analysis in the field of medicines; services of biotechnological, chemical and pharmacological laboratories, including scientific and technological research, in relation to the production of chemicals and biotechnological products for use in the preparation of pharmaceuticals; development of pharmaceutical preparations and medicines; development of technologies for the production of pharmaceutical semi finished and/or finished preparations; academic research, medical and biochemical research and development services; chemistry, laboratory technicians' and engineering services; research and development in the field of biotechnology; research into and development and testing of pharmaceutical and biochemical semi- finished products, in particular for use in medicines, research into and development and testing of medicines; development of test systems for pharmaceutical, medical and sanitizing preparations; services development and identification of and research into new drug targets ]

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Oct 7, 2024 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 14, 2024 INTS
INVALIDATION PROCESSED
Sep 14, 2024 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 13, 2024 INTR
CANCELLED SECTION 71
Jan 12, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 27, 2022 REM3
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 12, 2018 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 8, 2018 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 28, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 28, 2017 FICS
FINAL DISPOSITION PROCESSED
Sep 28, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 27, 2017 FICR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Aug 8, 2017 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Aug 8, 2017 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 8, 2017 APRE
REGISTERED-PRINCIPAL REGISTER
Jun 27, 2017 R.PR
LIMITATION OF GOODS RECEIVED FROM IB
Jun 23, 2017 LIMG
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 24, 2017 ETOP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 20, 2017 ADCH
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 6, 2017 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 10, 2017 NPUB
PUBLISHED FOR OPPOSITION
Jan 10, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 21, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 2, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 1, 2016 TROA
REFUSAL PROCESSED BY IB
Nov 11, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 27, 2016 RFCS
REFUSAL PROCESSED BY MPU
Oct 27, 2016 RFRR
APPLICATION FILING RECEIPT MAILED
Oct 11, 2016 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 7, 2016 RFCR
NON-FINAL ACTION WRITTEN
Oct 6, 2016 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 1, 2016 REPR